CD8A and neoplasm: 22875801 22875801 Feldmann A, Arndt C, Topfer K et al (2012) Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells.